ITGR Stock Analysis: Buy, Sell, or Hold?

ITGR - Integer Holdings Corporation

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$86.86
0.39 (0.45%) β–²
HOLD
MODERATE Confidence
Protect Your ITGR Gains
Last Updated: January 30, 2026
Earnings: Feb 19, 2026 17d

Get Alerted When ITGR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: ITGR is fairly valued with market pricing in 2.8% annual growth. Fine to hold or accumulate slowly on dips.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$8.78
Based on -30.9% avg growth
INTRINSIC VALUE TODAY
$5.45
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ITGR is currently trading at $86.86, which is considered extended relative to its 30-day fair value range of $79.77 to $86.28. The stock's valuation (Forward PE: 13.8) is in line with its historical norms (12.7). At these levels, the market is pricing in 2.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, ITGR is in a strong downtrend. The price is approaching resistance at $87.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $79.77 - $86.28
Company Quality Score 64/100 (BUY)
Options IV Signal 46th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 51.5%

Protect Your Profits

Holding ITGR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • NEUTRAL: Options fairly priced (IV 46th percentile)
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($85.57)
  • NEUTRAL: Market pricing in 2.8% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $79.77 - $86.28
Current vs Fair Value EXTENDED
Expected Move (7 Days) Β±$8.73 (10.1%)

Support & Resistance Levels

Support Level $83.39
Resistance Level $87.69
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 13.80
Wall Street Target $85.57 (-1.5%)
Revenue Growth (YoY) 8.4%
Earnings Growth (YoY) 12.5%
Profit Margin 4.8%
Valuation Premium vs History +2.8% premium
PE vs Historical 13.8 vs 12.7 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.8% (market-implied from PE analysis)
1-Year Target $89.29 (+3%)
2-Year Target $91.79 (+6%)
3-Year Target $94.36 (+9%)
3-Yr Target (if PE normalizes) (PE: 14β†’13) PE COMPRESSION $86.86 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: -65.8%) $137.64 (+59%)
Base: (SPY PE: 13.8, Growth: -65.8%) $85.16 (-2%)
Bear: (PE: 11.7, Growth: -65.8%) $72.38 (-17%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 35.35 | Current EPS (TTM): $2.43
Bull Case $188.98 (+118%)
Analyst growth 100.0%, PE expands to 38.9
Base Case $171.80 (+98%)
Market implied 100.0%, PE stable at 35.4
Bear Case $58.41 (-33%)
Severe decline -20.0%, PE contracts to 30.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 01, 2026 1:33 AM ET
Data refreshes hourly during market hours. Next update: 2:33 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$124 59 HOLD
DXCM
DexCom Inc
STRONG BUY
26 analysts
$85 65 BUY
ABT
Abbott Laboratories
BUY
28 analysts
$136 63 BUY
MDT
Medtronic PLC
BUY
32 analysts
$110 63 BUY
PODD
Insulet Corporation
STRONG BUY
23 analysts
$374 54 HOLD

Advanced ITGR Option Strategies

Professional options setups generated by AI based on today's ITGR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ITGR

ITGR Technical Chart ITGR Price Prediction ITGR Earnings Date ITGR Investment Advisor ITGR Fair Price Analyzer ITGR Options Advisor ITGR Options Chain ITGR Options Analysis ITGR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals